News Extra Medicines committee felt unable to recommend use of pentosan polyphosphate in vCJD BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7418.770-b (Published 02 October 2003) Cite this as: BMJ 2003;327:770 Article Related content Metrics Responses Peer review Related articles News NIH announces new strategy for research Published: 02 October 2003; BMJ 327 doi:10.1136/bmj.327.7418.765 News Small improvement seen in teenager with vCJD Published: 02 October 2003; BMJ 327 doi:10.1136/bmj.327.7418.765-a News Family finds hospital willing to give experimental CJD treatment Published: 04 January 2003; BMJ 326 doi:10.1136/bmj.326.7379.8/a See more Andrew Wakefield calls Trump “on our side” over vaccines after meeting BMJ December 05, 2016, 355 i6545; DOI: https://doi.org/10.1136/bmj.i6545 Drug firms need to tackle affordability BMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096 US sees rise in rare polio like syndrome of unknown cause BMJ November 07, 2016, 355 i5981; DOI: https://doi.org/10.1136/bmj.i5981 Authors’ reply to Eisenhut BMJ November 02, 2016, 355 i5787; DOI: https://doi.org/10.1136/bmj.i5787 A swollen painful foot BMJ November 02, 2016, 355 i5418; DOI: https://doi.org/10.1136/bmj.i5418 Cited by... Choice and equity: lessons from long term careFulltext PDF
